Y-mAbs Therapeutics Inc. (YMAB) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Y-mAbs Therapeutics Inc.

    NASDAQ: YMAB · Real-Time Price · USD
    8.61
    0.02 (0.23%)
    At close: Sep 15, 2025, 3:59 PM

    Y-mAbs Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 87.69M 84.82M 65.27M 34.9M
    Cost of Revenue
    		 15.25M 11.42M 7.57M 2.51M
    Gross Profit
    		 72.43M 73.4M 57.7M 32.38M
    Operating Income
    		 -31.2M -25.67M -94.81M -115.43M
    Interest Income
    		 1.39M 4.81M n/a n/a
    Pretax Income
    		 -29.81M -20.87M -95.57M -55.27M
    Net Income
    		 -29.67M -21.43M -95.57M -55.27M
    Selling & General & Admin
    		 54.65M 44.86M 60.94M 54.57M
    Research & Development
    		 48.99M 54.22M 91.57M 93.25M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 103.64M 99.08M 152.51M 147.82M
    Interest Expense
    		 n/a n/a 757K 1.85M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 118.89M 110.49M 160.08M 150.33M
    Income Tax Expense
    		 -146K 561K n/a 1.07M
    Shares Outstanding (Basic)
    		 44.33M 43.65M 43.7M 43.18M
    Shares Outstanding (Diluted)
    		 44.33M 43.65M 43.7M 43.18M
    EPS (Basic)
    		 -0.67 -0.49 -2.2 -1.28
    EPS (Diluted)
    		 -0.67 -0.49 -2.2 -1.28
    EBITDA
    		 -30.67M -24.94M -94.73M -54.49M
    EBIT
    		 -31.2M -25.67M -95.57M -55.27M
    Depreciation & Amortization
    		 535K 735K 839K 782K

    Add to Watchlist